Related Experiment Video
Updated: May 17, 2025

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Computational exploration of viral cell membrane structures for identifying novel therapeutic target
Kirtiman Mahata1, Manti Biswas1, Shrestha Sengupta1
1Computational Drug Design and Biomolecular Simulation Lab, Department of Bioinformatics, Maulana Abul Kalam Azad University of Technology, Haringhata, West Bengal, India.
Abstract:
The membrane proteins of viruses play a critical role, and they shield viruses and takes biochemical mechanisms like sticking to the host cell membrane, merging with them, building new viruses, and breaking free. These steps make sure the virus can infect and multiply. But the membrane proteins of Nipah, Zika, SARS-CoV-2, and Hendra virus can cause special kinds of infections. Nipah and Hendra viruses use their fusion protein to join with the host cell membrane. Their glycoprotein interacts with host receptors. The matrix protein helps to build and support the virus structure. Zika virus relies on its envelope protein to attach and fuse with host cells. Its membrane protein keeps the viral envelope stable. SARS-CoV-2 uses its spike protein to enter host cells and its envelope protein helps assemble new viruses. The membrane protein gives structural stability whereas the nucleocapsid protein interacts with the RNA genome. These viral membranes contain various kinds of lipids and proteins and they make up about 30 % of the membrane area. Yet, scientists find it hard to predict their molecular structure and different biological characters. The coarse-grained molecular dynamics simulations, enhanced sampling methods, and various structural bioinformatics investigations on viral proteins provide reliable scientific data. These investigations reveal viral membrane proteins' structural features, movement patterns, and thermodynamic properties. These computer methods are vital for drug discovery because it allows researchers to find new compounds that target viral membrane proteins to prevent their functions.
Insights
Viral membrane proteins are crucial for infection, but their complex structures are hard to predict. Advanced computational methods reveal their dynamics, aiding drug discovery for viruses like SARS-CoV-2.
Area of Science:
- Virology
- Structural Biology
- Computational Biology
Background:
- Viral membrane proteins are essential for virus life cycles, including host cell attachment, fusion, and assembly.
- Specific viruses like Nipah, Hendra, Zika, and SARS-CoV-2 utilize distinct membrane proteins for infection.
- Understanding viral membrane protein structure and function is challenging yet critical for therapeutic development.
Purpose of the Study:
- To investigate the structural features, dynamics, and thermodynamic properties of viral membrane proteins.
- To highlight the utility of computational methods in studying these complex viral components.
- To underscore the importance of this research for antiviral drug discovery.
Main Methods:
- Coarse-grained molecular dynamics simulations.
- Enhanced sampling techniques.
- Structural bioinformatics investigations of viral proteins.
Main Results:
- Computational methods provide reliable data on viral membrane protein structural features and movement patterns.
- These investigations reveal key thermodynamic properties of viral membrane proteins.
- The study elucidates the roles of specific proteins (e.g., fusion, spike, envelope) in viral infectivity.
Conclusions:
- Computational approaches are vital for deciphering the complex molecular characteristics of viral membrane proteins.
- This research facilitates the identification of novel drug targets within viral membrane proteins.
- Understanding these proteins is key to developing new strategies to combat viral infections.
More Related Videos
06:03Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018